Další formáty:
BibTeX
LaTeX
RIS
@article{41189, author = {Švajdová, Michaela and Sičák, Marián and Dubinský, Pavol and Slávik, Marek and Šlampa, Pavel and Kazda, Tomáš}, article_location = {BASEL}, article_number = {12}, doi = {http://dx.doi.org/10.3390/cancers12123510}, keywords = {nasopharyngeal cancer; recurrence; salvage surgery; re-irradiation; toxicity}, language = {eng}, issn = {2072-6694}, journal = {Cancers}, title = {Recurrent Nasopharyngeal Cancer: Critical Review of Local Treatment Options Including Recommendations during the COVID-19 Pandemic}, url = {https://www.mdpi.com/2072-6694/12/12/3510}, volume = {12}, year = {2020} }
TY - JOUR ID - 41189 AU - Švajdová, Michaela - Sičák, Marián - Dubinský, Pavol - Slávik, Marek - Šlampa, Pavel - Kazda, Tomáš PY - 2020 TI - Recurrent Nasopharyngeal Cancer: Critical Review of Local Treatment Options Including Recommendations during the COVID-19 Pandemic JF - Cancers VL - 12 IS - 12 SP - 1-19 EP - 1-19 PB - MDPI SN - 2072-6694 KW - nasopharyngeal cancer KW - recurrence KW - salvage surgery KW - re-irradiation KW - toxicity UR - https://www.mdpi.com/2072-6694/12/12/3510 N2 - Options for the curative treatment of locally recurrent nasopharyngeal carcinoma include surgery or re-irradiation. Both approaches have been scientifically explored, yet there is no consensus on the indication or definitive preference of the above two salvage treatments. The aim of this review is to summarize the current evidence on the local treatment of recurrent nasopharyngeal carcinoma. The feasibility, safety, and efficacy of salvage surgery and radical re-irradiation are discussed. Recommendations on treatment modifications during the coronavirus disease 2019 pandemic are included as well. Recurrent nasopharyngeal carcinoma represents an extremely challenging therapeutic situation. Given the vulnerability of the already pretreated neurological structures surrounding the nasopharynx, any potential salvage retreatment option bears a significant risk of severe complications that result in high treatment-related morbidity, quality of life deterioration, and even mortality. Yet, with careful patient selection, long-term survival may be achieved after local retreatment in a subgroup of patients with local or regional relapse of nasopharyngeal cancer. Early detection of the recurrence represents the key to therapeutic success, and in the case of early stage disease, several curative treatment options can be offered to the patient, albeit with minimal support in prospective clinical data. In this article, an up-to-date review of published evidence on modern surgical and radiation therapy treatment options is summarized, including currently recommended treatment modifications of both therapeutic approaches during the coronavirus disease 2019 pandemic. ER -
ŠVAJDOVÁ, Michaela, Marián SIČÁK, Pavol DUBINSKÝ, Marek SLÁVIK, Pavel ŠLAMPA a Tomáš KAZDA. Recurrent Nasopharyngeal Cancer: Critical Review of Local Treatment Options Including Recommendations during the COVID-19 Pandemic. \textit{Cancers}. BASEL: MDPI, roč.~12, č.~12, s.~1-19. ISSN~2072-6694. doi:10.3390/cancers12123510. 2020.
|